El­e­va­tion On­col­o­gy stops work on ADC, lays off work­ers; As­traZeneca’s CEPI fund­ing

Plus, news about Cen­tu­ry Ther­a­peu­tics, Ake­bia Ther­a­peu­tics, Eye­n­ovia, Be­taliq, Alvotech, Genen­ta Sci­ence, Aa­di Bio­science, and Ex­i­cure:

El­e­va­tion On­col­o­gy drops ADC, lays off 70%: The Boston …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER